Markus Raderer

4.0k total citations
62 papers, 1.5k citations indexed

About

Markus Raderer is a scholar working on Oncology, Epidemiology and Neurology. According to data from OpenAlex, Markus Raderer has authored 62 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 27 papers in Epidemiology and 13 papers in Neurology. Recurrent topics in Markus Raderer's work include Neuroendocrine Tumor Research Advances (25 papers), Lung Cancer Research Studies (21 papers) and Neuroblastoma Research and Treatments (9 papers). Markus Raderer is often cited by papers focused on Neuroendocrine Tumor Research Advances (25 papers), Lung Cancer Research Studies (21 papers) and Neuroblastoma Research and Treatments (9 papers). Markus Raderer collaborates with scholars based in Austria, United States and Germany. Markus Raderer's co-authors include Michael Hejna, Werner Scheithauer, Amir Kurtaran, P. Angelberger, Robert Dudczak, Gerhard Hamilton, Georg‐Christian Funk, Rolf Ziesche, Ventzislav Petkov and Karin Vonbank and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Markus Raderer

62 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markus Raderer Austria 20 598 380 369 328 296 62 1.5k
Yasuo Ejima Japan 20 379 0.6× 394 1.0× 210 0.6× 110 0.3× 171 0.6× 49 1.3k
Giovannella Palmieri Italy 26 544 0.9× 432 1.1× 393 1.1× 668 2.0× 81 0.3× 113 1.9k
Salvatore Tumolo Italy 24 937 1.6× 431 1.1× 149 0.4× 127 0.4× 195 0.7× 106 1.8k
Inga Buchmann Germany 20 507 0.8× 376 1.0× 461 1.2× 525 1.6× 467 1.6× 49 1.8k
Michela Donadio Italy 23 1.1k 1.8× 330 0.9× 214 0.6× 152 0.5× 253 0.9× 68 1.8k
J. Kirk Martin United States 25 907 1.5× 609 1.6× 377 1.0× 137 0.4× 265 0.9× 48 1.7k
Ichiro Fukai Japan 25 536 0.9× 552 1.5× 224 0.6× 419 1.3× 74 0.3× 87 1.9k
Mirella Marino Italy 25 398 0.7× 181 0.5× 727 2.0× 1.7k 5.1× 271 0.9× 82 2.3k
Christoph Thorns Germany 25 698 1.2× 194 0.5× 143 0.4× 130 0.4× 716 2.4× 83 1.8k
Dan Combs United States 8 233 0.4× 143 0.4× 188 0.5× 257 0.8× 321 1.1× 10 1.2k

Countries citing papers authored by Markus Raderer

Since Specialization
Citations

This map shows the geographic impact of Markus Raderer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Raderer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Raderer more than expected).

Fields of papers citing papers by Markus Raderer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Raderer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Raderer. The network helps show where Markus Raderer may publish in the future.

Co-authorship network of co-authors of Markus Raderer

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Raderer. A scholar is included among the top collaborators of Markus Raderer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Raderer. Markus Raderer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zeilinger, Elisabeth L., Claudia Oppenauer, Matthias Knefel, et al.. (2024). Prevalence and biopsychosocial indicators of fatigue in cancer patients. Cancer Medicine. 13(11). e7293–e7293. 2 indexed citations
2.
Kiesewetter, Barbara, Peter Mazal, Elisabeth Kretschmer‐Chott, Marius E. Mayerhoefer, & Markus Raderer. (2022). Pulmonary neuroendocrine tumours and somatostatin receptor status: an assessment of unlicensed use of somatostatin analogues in the clinical practice. ESMO Open. 7(3). 100478–100478. 8 indexed citations
3.
Rabitsch, Werner, Philipp Wohlfarth, Edit Porpaczy, et al.. (2017). Gender-Specific Aspects in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation: A Single-Center Experience. Oncology. 93(5). 295–301. 6 indexed citations
4.
Pavel, Marianne, Jarosław B. Ćwikła, Markus Raderer, et al.. (2015). 2370 Relative risk analysis of safety profile of lanreotide autogel/depot vs. placebo in patients with pancreatic and intestinal neuroendocrine tumours. European Journal of Cancer. 51. S460–S460. 1 indexed citations
5.
Krauth, Maria‐Theresa, Yasamin Majlesi, Stefan Florian, et al.. (2005). Cell Surface Membrane Antigen Phenotype of Human Gastrointestinal Mast Cells. International Archives of Allergy and Immunology. 138(2). 111–120. 21 indexed citations
6.
Hejna, Michael & Markus Raderer. (2005). Neoadjuvante Therapie des resektablen Ösophaguskarzinoms. Zeitschrift für Gastroenterologie. 43(10). 1141–1147. 6 indexed citations
7.
Wöhrer, Stefan, Markus Raderer, H. Kaufmann, et al.. (2005). Effective Treatment of Indolent Non-Hodgkin’s Lymphomas with Mitoxantrone, Chlorambucil and Prednisone. Oncology Research and Treatment. 28(2). 73–78. 12 indexed citations
8.
Becherer, Alexander, Georgios Karanikas, Patrick Wunderbaldinger, et al.. (2004). Imaging of advanced neuroendocrine tumors with (18)F-FDOPA PET.. PubMed. 45(7). 1161–7. 140 indexed citations
9.
Wöhrer, Stefan, Jutta Ackermann, Sonja Seidl, et al.. (2004). Effective treatment of primary plasma cell leukemia with thalidomide and dexamethasone – a case report. The Hematology Journal. 5(4). 361–363. 10 indexed citations
10.
Petkov, Ventzislav, Wilhelm Mosgoeller, Rolf Ziesche, et al.. (2003). Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension. Journal of Clinical Investigation. 111(9). 1339–1346. 249 indexed citations
11.
Valencak, Julia, Franz Trautinger, Wolfgang Fiebiger, & Markus Raderer. (2002). Complete remission of chronic plaque psoriasis and gastric marginal zone B-cell lymphoma of MALT type after treatment with 2-chlorodeoxyadenosine. Annals of Hematology. 81(11). 662–665. 5 indexed citations
12.
Hoffmann, Martha, Georg Oberhuber, Kurt Kletter, Alexander Becherer, & Markus Raderer. (2002). Imaging of Cutaneous Recurrence of Gastric Cancer with F-18 FDG Positron Emission Tomography. Clinical Nuclear Medicine. 27(10). 731–732. 6 indexed citations
13.
Wenzel, Catharina, Karin Dieckmann, Wolfgang Fiebiger, et al.. (2001). CD5 Expression in a Lymphoma of the Mucosa-Associated Lymphoid Tissue (MALT)-Type as a Marker for Early Dissemination and Aggressive Clinical Behaviour. Leukemia & lymphoma. 42(4). 823–829. 39 indexed citations
14.
Scheithauer, Werner, H. Ulrich-Pur, Markus Raderer, et al.. (1999). Phase II trial of high-dose gemcitabine in patients with metastatic pancreatic adenocarcinoma. European Journal of Cancer. 35. S147–S147. 3 indexed citations
15.
Raderer, Markus, Georg Oberhuber, Ludwig Wagner, et al.. (1999). Successful Symptomatic Management of a Patient with Ménétrier’s Disease with Long-Term Antibiotic Treatment. Digestion. 60(4). 358–362. 16 indexed citations
16.
Müller, Christian, Johann Pidlich, Edward Penner, et al.. (1998). Treatment of pruritus in chronic liver disease with the 5-hydroxytryptamine receptor type 3 antagonist ondansetron. European Journal of Gastroenterology & Hepatology. 10(10). 865–870. 84 indexed citations
17.
Hejna, Michael, Gabriela Kornek, Markus Raderer, et al.. (1998). Mitomycin C, Vinorelbine, Carboplatin plus Granulocyte-Macrophage Colony-Stimulating Factor for Treatment of Advanced Non-Small Cell Lung Carcinoma. Oncology. 55(6). 538–542. 4 indexed citations
18.
Zojer, Niklas, Michael Fiegl, Leonhard Müllauer, et al.. (1998). Chromosomal imbalances in primary and metastatic pancreatic carcinoma as detected by interphase cytogenetics: basic findings and clinical aspects. British Journal of Cancer. 77(8). 1337–1342. 26 indexed citations
19.
Raderer, Markus, Thomas Maca, Johannes Kästner, et al.. (1995). Tolerance of the Novel Chemosensitizer Dexverapamil in Combination with Anthracycline Chemotherapy: a Prospective Toxicity Analysis in Advanced Gastrointestinal Cancer. Oncology Research and Treatment. 18(5). 462–467. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yasuo Ejima Breakdown of academic impact, for papers by Giovannella Palmieri Breakdown of academic impact, for papers by Salvatore Tumolo Breakdown of academic impact, for papers by Inga Buchmann Breakdown of academic impact, for papers by Michela Donadio Breakdown of academic impact, for papers by J. Kirk Martin Breakdown of academic impact, for papers by Ichiro Fukai Breakdown of academic impact, for papers by Mirella Marino Breakdown of academic impact, for papers by Christoph Thorns Breakdown of academic impact, for papers by Dan Combs
Rankless by CCL
2026